+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Mutation Detection Kits In Genome Editing Market by Genome, End-Use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5715885
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Mutation Detection Kits In Genome Editing Market grew from USD 192.80 million in 2023 to USD 222.74 million in 2024. It is expected to continue growing at a CAGR of 15.83%, reaching USD 539.51 million by 2030.

As a Market Research Analyst at 360iResearch focusing on Mutation Detection Kits within Genome Editing, it is crucial to grasp the scope and definition, understanding their necessity, applications, and end-user scope. These kits play a pivotal role in precise genome editing, offering essential tools for identifying specific gene alterations required in research and clinical settings. They are primarily utilized in diagnostics, gene therapy research, cancer research, and drug development, with end-users ranging from academic institutions and research laboratories to biotech and pharmaceutical companies. Key growth influences include the increasing investment in genetic engineering, the rise of personalized medicine, and technological advancements that enhance genetic analysis precision. Recent technological advances, such as CRISPR and next-generation sequencing, have expanded potential opportunities, recommending stakeholders to invest in integrating these technologies with mutation detection kits for enhanced precision and efficiency.

However, the market faces limitations, including high costs, intricate regulatory landscapes, and ethical concerns regarding genome editing. The complexity of the technology can also pose significant barriers, with challenges in standardization and the need for highly specialized skills. To mitigate these challenges, firms should focus on developing cost-effective and user-friendly kits, potentially through collaborations with academic institutions for knowledge-sharing and innovation. Areas ripe for innovation include automation of detection processes, improving detection sensitivity, and expanding the range of detectable mutations. Exploring artificial intelligence applications to improve accuracy and efficiency in genome editing represents another promising avenue. The nature of the market is competitive and rapidly evolving, driven by continuous technological advancements and a burgeoning interest in genomic solutions. For sustained growth, businesses should prioritize research in emerging technologies and consistently adapt to regulatory changes, ensuring compliance and ethical alignment. By doing so, they can maintain a competitive edge and fully capitalize on the growing demand for precision in genetic editing solutions.

Understanding Market Dynamics in the Mutation Detection Kits In Genome Editing Market

The Mutation Detection Kits In Genome Editing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence of genetic disorders and cancer
    • Rising investments in genetic research and personalized medicine
  • Market Restraints
    • High costs and complex regulations associated with genome editing technologies
  • Market Opportunities
    • Innovations in sequencing technologies and bioinformatics
    • Increasing collaboration between biotech firms and research institutions
  • Market Challenges
    • Technical limitations and accuracy concerns associated with the mutation detection kits

Exploring Porter’s Five Forces for the Mutation Detection Kits In Genome Editing Market

Porter’s Five Forces framework further strengthens the insights of the Mutation Detection Kits In Genome Editing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Mutation Detection Kits In Genome Editing Market

External macro-environmental factors deeply influence the performance of the Mutation Detection Kits In Genome Editing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Mutation Detection Kits In Genome Editing Market

The Mutation Detection Kits In Genome Editing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Mutation Detection Kits In Genome Editing Market

The Mutation Detection Kits In Genome Editing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Mutation Detection Kits In Genome Editing Market

The Mutation Detection Kits In Genome Editing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mutation Detection Kits In Genome Editing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Amoy Diagnostics Co., Ltd., Applied Biological Materials, Inc., Bio-Rad Laboratories, BIOKÉ, B.V. by Cell Signaling Technology, Inc., Bioneer Corporation, Biovision Inc. by Abcam Limited, GenScript Biotech Corporation, Illumina, Inc., Integrated DNA Technologies, Inc. by Danaher Corporation, Launch Diagnostics Limited by Avacta Group Plc, LGC Biosearch Technologies, Lonza Group AG, Medaysis Company, Merck KGaA, Mylab Discovery Solutions Pvt. Ltd., New England Biolabs, New England Biolabs, Inc., Origene Technologies, Inc., Promega Corporation, Qiagen N.V., Synthego Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., TransGen Biotech Co., Ltd., and TRUPCR by Kilpest India Limited.

Market Segmentation & Coverage

This research report categorizes the Mutation Detection Kits In Genome Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Genome
    • CRISPR/Cas9
    • Meganucleases
    • TALENs/MegaTALs
    • ZFN
  • End-Use
    • Academic Research Institutes
    • Biotechnology & Pharmaceutical Companies
    • Contract Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Mutation Detection Kits In Genome Editing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Wide usage of genome editing techniques
5.1.1.2. R&D in polymorphisms and unknown mutations in genome sequences
5.1.1.3. Increasing number of CRISPR-Cas derived reagents to offer applications for gene editing
5.1.2. Restraints
5.1.2.1. Inadequate expertise for mutation detection
5.1.3. Opportunities
5.1.3.1. Emerging several novel methods for mutation detection in DNA
5.1.3.2. Increasing investment in the development of mutation detection kits
5.1.4. Challenges
5.1.4.1. Regulatory and ethical concerns
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Mutation Detection Kits In Genome Editing Market, by Genome
6.1. Introduction
6.2. CRISPR/Cas9
6.3. Meganucleases
6.4. TALENs/MegaTALs
6.5. ZFN
7. Mutation Detection Kits In Genome Editing Market, by End-Use
7.1. Introduction
7.2. Academic Research Institutes
7.3. Biotechnology & Pharmaceutical Companies
7.4. Contract Research Organizations
8. Americas Mutation Detection Kits In Genome Editing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Mutation Detection Kits In Genome Editing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Mutation Detection Kits In Genome Editing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Amoy Diagnostics Co., Ltd.
12.1.2. Applied Biological Materials, Inc.
12.1.3. Bio-Rad Laboratories
12.1.4. BIOKÉ
12.1.5. Biovision Inc.
12.1.6. GenScript
12.1.7. Integrated DNA Technologies, Inc.
12.1.8. Launch Diagnostics Limited
12.1.9. Medaysis Company
12.1.10. Mylab Discovery Solutions Pvt. Ltd.
12.1.11. New England Biolabs
12.1.12. Promega Corporation
12.1.13. Takara Bio Inc.
12.1.14. Thermo Fisher Scientific Inc.
12.1.15. TRUPCR by Kilpest India Limited
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. MUTATION DETECTION KITS IN GENOME EDITING MARKET RESEARCH PROCESS
FIGURE 2. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2023 VS 2030
FIGURE 3. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MUTATION DETECTION KITS IN GENOME EDITING MARKET DYNAMICS
FIGURE 7. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2023 VS 2030 (%)
FIGURE 8. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 10. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. MUTATION DETECTION KITS IN GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. MUTATION DETECTION KITS IN GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. MUTATION DETECTION KITS IN GENOME EDITING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 6. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY MEGANUCLEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TALENS/MEGATALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY ZFN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 11. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 21. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 22. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 23. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 24. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 33. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 34. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 35. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 36. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 39. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 40. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 51. THAILAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 52. THAILAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 59. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 61. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 62. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 63. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 64. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 65. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 67. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 70. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 71. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 76. NORWAY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 77. NORWAY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 78. POLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 79. POLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 80. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 81. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 88. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 89. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 94. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 95. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 100. MUTATION DETECTION KITS IN GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 101. MUTATION DETECTION KITS IN GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 102. MUTATION DETECTION KITS IN GENOME EDITING MARKET LICENSE & PRICING

Companies Mentioned

The leading players in the Mutation Detection Kits In Genome Editing market, which are profiled in this report, include:
  • Agilent Technologies, Inc.
  • Amoy Diagnostics Co., Ltd.
  • Applied Biological Materials, Inc.
  • Bio-Rad Laboratories
  • BIOKÉ, B.V. by Cell Signaling Technology, Inc.
  • Bioneer Corporation
  • Biovision Inc. by Abcam Limited
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc. by Danaher Corporation
  • Launch Diagnostics Limited by Avacta Group Plc
  • LGC Biosearch Technologies
  • Lonza Group AG
  • Medaysis Company
  • Merck KGaA
  • Mylab Discovery Solutions Pvt. Ltd.
  • New England Biolabs
  • New England Biolabs, Inc.
  • Origene Technologies, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Synthego Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TransGen Biotech Co., Ltd.
  • TRUPCR by Kilpest India Limited

Methodology

Loading
LOADING...

Table Information